Eli Lilly And Company

This study tested whether a new drug called peresolimab could help adults with moderate-to-severe rheumatoid arthritis. Researchers compared the drug against a placebo in 491 participants over 12 weeks to see if it reduced joint pain, swelling, and improved daily activities. The …

This early-stage study aimed to test the safety of a new drug called LY3872386. It involved healthy volunteers and people with atopic dermatitis (eczema) to see how their bodies handled the drug. The study was terminated early, so no final results on effectiveness are available.

This was an early-stage study to test the safety and find the right dose of an experimental drug called LY3405105 for people with advanced solid tumors. The trial enrolled 54 participants with various advanced cancers to see if the drug was safe and if it showed any signs of shri…

This study aimed to find the right dose and check the safety of the drug baricitinib for children aged 1 to 18 who were hospitalized with COVID-19. It was designed to see if the drug could help control the disease and prevent kids from needing more serious breathing support. The …

This study tested whether an experimental drug called LY3540378 could help adults with a specific type of worsening heart failure where the heart pumps normally but doesn't relax properly. The trial enrolled 332 participants who had recently been hospitalized or needed urgent tre…

This study tested an experimental drug called LY3454738 to see if it could reduce the severity of moderate-to-severe eczema (atopic dermatitis) in adults. It was a Phase 2 trial involving 234 participants who were compared against a placebo group over 52 weeks. The main goal was …

This early-stage study tested the safety of a new drug called LY3127804, both alone and combined with an existing cancer drug (ramucirumab), in 62 people with advanced solid tumors. The main goal was to find safe dosage levels and understand how the body processes these drugs. Th…

This study tested a medicine called lasmiditan to see if it could safely and effectively stop migraine attacks in children and teenagers aged 6 to 17. The trial involved 851 young participants and compared different doses of the medicine to a placebo (a pill with no medicine). Th…

This study aimed to evaluate the long-term safety and effectiveness of lasmiditan for treating migraine attacks in children aged 6 to 17. The 12-month trial followed 566 young participants who had previously completed related studies, focusing on side effects and migraine relief.…

This was an early-stage study to check the safety and side effects of a new oral drug called LY3526318 in healthy people. It also measured how the drug moves through and is processed by the body. The study was terminated after enrolling 76 participants and did not aim to treat an…

This early-stage study aimed to check the safety and side effects of a new drug called LY3463251 when given as an injection under the skin. It involved 118 healthy and overweight volunteers to see how their bodies handled single and multiple doses. The main goal was to gather bas…